Nastya Zelenovska is a digital marketing and content strategy specialist with over 15 years of experience working with international brands and media platforms. Her expertise lies in data-driven marketing, editorial distribution, and building visibility strategies that scale across markets.
At StartupMafia, Nastya supports European startups by providing actionable insights on marketing, media, and growth strategies, helping them scale confidently and compete across international markets.
Ringtime, a Ghent-based startup focused on automating recruitment for blue-collar roles, has raised €1.8 million in Seed funding led by Volta Ventures, with participation from Syndicate One, JK...
Cleavr, a Paris-based AI startup focused on autonomous accounts receivable management, has raised €1 million in a funding round led by Kima Ventures and Better Angle, with participation from Raphaël...
Earth Blox, an Edinburgh-based startup analyzing the impact of climate change on financial performance, has secured €6.9 million in funding to expand its team, accelerate product...
London-based Cocoon Carbon has secured $15 million in Series A financing to accelerate deployment of its low-carbon cement alternative. The round was led by 2150 and Brick &...
Scinus Group, a Utrecht-based biotech company, has raised €3 million in a strategic investment round led by Myosotis Investments, with participation from Demcon Innovation Fund. The...
London-based Ternary Therapeutics, a BioTech startup developing AI-driven molecular glues, has raised €4.1 million (£3.6 million) in Seed funding. The round was led by daphni, with...
Oxford Medical Simulation (OMS), a UK-based startup providing AI-driven virtual reality healthcare training, has raised €5.78 million (£5 million) in growth funding from Salica Investments....
Dortmund-based iDEL Therapeutics has closed a €9 million Seed financing round to advance its pipeline of cancer therapeutics that are delivered directly into the cytosol of...
Schönefeld-based Kupando, a biopharmaceutical startup developing a dual TLR 4/7 agonist to stimulate innate immunity for oncology and infectious diseases, has raised an additional...
Rivia, a Zurich-based startup focused on AI-driven analytics and clinical trial data infrastructure for BioTech companies, has announced a €13 million ($15 million) Series...